Research Identifies Biomarkers in Blood to Fine-Tune Breast Cancer Interventions

Research identifies biomarkers in blood to fine-tune breast cancer interventions

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood, research from the University of Michigan and the University of Kansas suggests.

Capturing cancer cells from blood could help doctors choose the right breast cancer treatment

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood, research from the University of Michigan and the University of Kansas suggests.

Isolating Cancer Cells from Blood: A Step Towards Personalized Breast

Breast cancer remains one of the most significant health challenges faced by women globally, affecting approximately 2.3 million women today. Among these, a notable proportion—around 25%—are diagnosed with ductal carcinoma in situ (DCIS), an early-stage breast cancer characterized by cancer cells confined to the milk ducts. While patients diagnosed with DCIS often have an optimistic […]